New Therapeutic Approaches Targeted at the Late Stages of the HIV-1 Replication Cycle
Tags: HIV infections -- Treatment; VIRUSES -- Reproduction; ANTIRETROVIRAL agents; DRUG targeting; DRUG development; PROTEINS -- Structure; CLINICAL trials
Related Articles
- Targeting HIV: Past, Present and Future. Zeier, Mich�le D.; Nachega, Jean B. // Infectious Disorders - Drug Targets;Apr2011, Vol. 11 Issue 2, p98
No abstract available.
- Antiretroviral dynamics determines HIV evolution and predicts therapy outcome. Rosenbloom, Daniel I S; Hill, Alison L; Rabi, S Alireza; Siliciano, Robert F; Nowak, Martin A // Nature Medicine;Sep2012, Vol. 18 Issue 9, p1378
Despite the high inhibition of viral replication achieved by current anti-HIV drugs, many patients fail treatment, often with emergence of drug-resistant virus. Clinical observations show that the relationship between adherence and likelihood of resistance differs dramatically among drug...
- Statistical Methods in Recent HIV Noninferiority Trials: Reanalysis of 11 Trials. Flandre, Philippe // PLoS ONE;2011, Vol. 6 Issue 9, p1
Background: In recent years the "noninferiority" trial has emerged as the new standard design for HIV drug development among antiretroviral patients often with a primary endpoint based on the difference in success rates between the two treatment groups. Different statistical methods have been...
- Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection. Chamberland, A.; Sylla, M.; Boulassel, M. R.; Baril, J.-G.; C�t�, P.; Thomas, R.; Trottier, B.; Rouleau, D.; Routy, J.-P.; Tremblay, C. // International Journal of STD & AIDS;Mar2011, Vol. 22 Issue 3, p146
The rapid evolution of HIV-1 is a major obstacle to viral eradication. Early antiretroviral therapy (ART) during primary HIV-1 infection could limit viral diversity. Eighteen patients recently infected with HIV-1 were selected. Nine initiated ART soon after enrolment and nine remained untreated....
- Recent Advances in the Development of Small-molecule CCR5 Inhibitors for HIV. Tao Liu; Zhiyong Weng; Xiaowu Dong; Yongzhou Hu // Mini Reviews in Medicinal Chemistry;Nov2010, Vol. 10 Issue 13, p1277
No abstract available.
- CHAPTER 11: ANTIRETROVIRAL THERAPY FOR THE TREATMENT OF HIV INFECTION. // TB/HIV: A Clinical Manual;2004, p137
The article examines the use of antiretroviral therapy (ART) in treating human immunodeficiency virus (HIV) infection. The development of ART led to the launch of highly active ART (HAART). HAART, a combination of at least three antiretroviral (ARV) drugs, is the global standard of care in the...
- Different patterns of HIV-1 DNA after therapy discontinuation. Re, Maria Carla; Vitone, Francesca; Sighinolfi, Laura; Schiavone, Pasqua; Ghinelli, Florio; Gibellini, Davide // BMC Infectious Diseases;2005, Vol. 5 Issue 1, p69
Background: By persisting in infected cells for a long period of time, proviral HIV-1 DNA can represent an alternative viral marker to RNA viral load during the follow-up of HIV-1 infected individuals. In the present study sequential blood samples of 10 patients under antiretroviral treatment...
- Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Sigal, Alex; Kim, Jocelyn T.; Balazs, Alejandro B.; Dekel, Erez; Mayo, Avi; Milo, Ron; Baltimore, David // Nature;9/1/2011, Vol. 477 Issue 7362, p95
Latency and ongoing replication have both been proposed to explain the drug-insensitive human immunodeficiency virus (HIV) reservoir maintained during antiretroviral therapy. Here we explore a novel mechanism for ongoing HIV replication in the face of antiretroviral drugs. We propose a model...
- Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration. Azzoni, Livio; Foulkes, Andrea S.; Papasavvas, Emmanouil; Mexas, Angela M.; Lynn, Kenneth M.; Mounzer, Karam; Tebas, Pablo; Jacobson, Jeffrey M.; Frank, Ian; Busch, Michael P.; Deeks, Steven G.; Carrington, Mary; O'Doherty, Una; Kostman, Jay; Montaner, Luis J. // Journal of Infectious Diseases;1/15/2013, Vol. 207 Issue 2, p213
Background. Antiretroviral therapy (ART)�mediated immune reconstitution fails to restore the capacity of the immune system to spontaneously control human immunodeficiency virus (HIV) replication.Methods. A total of 23 HIV type 1 (HIV-1)�infected, virologically suppressed subjects receiving...
